Tacey Viegas - Mar 26, 2024 Form 3 Insider Report for AgeX Therapeutics, Inc. (SER)

Role
COO and Secretary
Signature
/s/ Tacey Viegas
Stock symbol
SER
Transactions as of
Mar 26, 2024
Transactions value $
$0
Form type
3
Date filed
4/3/2024, 08:08 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SER Common Stock 58.6K Mar 26, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SER Stock Option (right to buy) Mar 26, 2024 Common Stock 204K $0.06 Direct F1, F2
holding SER Stock Option (right to buy) Mar 26, 2024 Common Stock 138K $0.06 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of capital stock of the corporation then known as Serina Therapeutics, Inc. ("Serina AL") were converted into shares of the Issuer pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of August 29, 2023, by and among the Issuer, Canaria Transaction Corporation and Serina AL (the "Merger Agreement"). Pursuant to the terms of the Merger Agreement, each share of capital stock was exchanged for 0.97682654 shares of the Issuer's common stock, giving effect to a reverse split of the Issuer's common stock of 1-for-35.17.
F2 The stock options are fully vested.